Flow cytometry experiments identifying different types of t-cells isolated from cancer tissue.

This research focuses on utilising PARP inhibitors to activate the cGAS-STING pathway, aiming to harness immune responses for cancer treatment through combination therapies. The experimental approach involves cultivating T-cells from cancer tissues, establishing co-cultures with cancer organoids, and using flow cytometry to characterise immune activity. Current progress includes successful T-cell cultivation, detailed immune analysis, and learnings from early experiments. Future directions...